Pills masthead

Fundamentals

Select the financial statements you wish to view below.  The reports below may be viewed on either an annual or quarterly basis.

NYSELCI
All numbers in thousands USD
Period Ending
Jun 30, 2019
Jun 30, 2018
Jun 30, 2017
Jun 30, 2016
Net Income
(272,107)
28,690
(581)
44,782
Operating Activities, Cash Flows Provided By or Used In
Depreciation
55,594
55,115
55,340
33,433
Changes In Accounts Receivables
84,949
(48,585)
1,701
15,149
Changes In Assets and Liabilities
73,430
(65,748)
(4,760)
42,310
Changes In Inventories
(2,336)
(19,031)
(7,700)
15,296
Changes In Other Operating Activities
236,780
168,082
121,373
(15,693)
Total Cash Flow From Operating Activities
176,310
118,523
165,373
135,277
Investing Activities, Cash Flows Provided By or Used In
Capital Expenditures
(27,340)
(71,354)
(48,694)
(24,267)
Investments
0
30,404
(10,083)
(638)
Other Cash flows from Investing Activities
20,050
(10,226)
112
(934,162)
Total Cash Flows From Investing Activities
(7,290)
(51,176)
(58,665)
(959,067)
Financing Activities, Cash Flows Provided By or Used In
Dividends Paid
--
--
--
--
Sale/Purchase of Stock
588
(500)
920
2,865
Net Borrowings
(126,743)
(85,705)
(178,233)
878,577
Other Cash Flows from Financing Activities
(1,102)
0
(36,500)
(33,223)
Total Cash Flows From Financing Activities
(127,257)
(86,205)
(213,813)
848,219
Effect Of Exchange Rate Changes
(100)
(293)
73
0
Change In Cash and Cash Equivalents
41,763
(18,858)
(107,105)
24,429